Management and Preventive Measures for Febrile Neutropenia.

about

Management and Preventive Measures for Febrile Neutropenia.

Item

http://www.wikidata.org/entity/Q54945637

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Management and Preventive Measures for Febrile Neutropenia.

@en

Management and Preventive Measures for Febrile Neutropenia.

@nl

type

Item

label

Management and Preventive Measures for Febrile Neutropenia.

@en

Management and Preventive Measures for Febrile Neutropenia.

@nl

prefLabel

Management and Preventive Measures for Febrile Neutropenia.

@en

Management and Preventive Measures for Febrile Neutropenia.

@nl

P1476

Management and Preventive Measures for Febrile Neutropenia.

@en

P2093

Austin J Lucas

http://www.w3.org/2001/XMLSchema#string

Jacqueline L Olin

http://www.w3.org/2001/XMLSchema#string

Megan D Coleman

http://www.w3.org/2001/XMLSchema#string

P2860

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.

Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.

Management of febrile neutropenia in the era of bacterial resistance

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

Distinct inflammatory mediator patterns characterize infectious and sterile systemic inflammation in febrile neutropenic hematology patients.

P304

228-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29622943

http://www.w3.org/2001/XMLSchema#string

P932

5871243

http://www.w3.org/2001/XMLSchema#string